Details for: CDK8
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 33.78rCSI 40.35%PRS 33.61
-
CSI 31.96rCSI 53.65%PRS 33.72
-
CSI 30.15rCSI 48.48%PRS 35.84
-
CSI 25.89rCSI 47.05%PRS 43.37
-
CSI 25.78rCSI 32.08%PRS 32.06
-
CSI 19.09rCSI 33.71%PRS 32.8
-
CSI 19.03rCSI 24.53%PRS 34.77
-
CSI 17.65rCSI 55.15%PRS 35.11
-
CSI 17.38rCSI 54.36%PRS 37.46
-
CSI 17.12rCSI 41.61%PRS 32.63
-
CSI 16.26rCSI 43.16%PRS 63.71
-
CSI 15.82rCSI 59.79%PRS 34.58
-
CSI 15.55rCSI 34.35%PRS 37.9
-
CSI 14.89rCSI 53.57%PRS 32.49
-
CSI 14.55rCSI 17.42%PRS 69.25
-
CSI 13.9rCSI 22.37%PRS 40.68
-
CSI 13.18rCSI 12.71%PRS 41
-
CSI 11.31rCSI 16.03%PRS 46.96
-
CSI 11.21rCSI 22.74%PRS 31.87
-
CSI 10.17rCSI 17.93%PRS 48.02
-
CSI 9.77rCSI 28.31%PRS 41.13
-
CSI 9.73rCSI 22.18%PRS 48.24
-
CSI 9.58rCSI 23.71%PRS 48.3
-
CSI 9.36rCSI 24.33%PRS 70.88
-
CSI 9.26rCSI 54.55%PRS 35.16
-
CSI 8.77rCSI 11.27%PRS 44.87
-
CSI 8.75rCSI 15.13%PRS 40.83
-
CSI 8.68rCSI 10.02%PRS 44.48
-
CSI 8.27rCSI 22.03%PRS 41.55
-
CSI 7.87rCSI 15.8%PRS 39.94
-
CSI 7.64rCSI 17.44%PRS 43.26
-
CSI 7.38rCSI 10.25%PRS 49.8
-
CSI 7.32rCSI 32.15%PRS 47.58
-
CSI 7.21rCSI 11.5%PRS 43.95
-
CSI 7.13rCSI 52.42%PRS 37.83
-
CSI 6.95rCSI 15.77%PRS 55.68
-
CSI 6.89rCSI 11.35%PRS 55.93
-
CSI 6.61rCSI 11.87%PRS 43.7
-
CSI 6.57rCSI 11.52%PRS 42.51
-
CSI 6.51rCSI 8.35%PRS 48.31
-
CSI 6.36rCSI 16.52%PRS 54.87
-
CSI 6.35rCSI 4.7%PRS 43.45
-
CSI 6.3rCSI 21.58%PRS 40.73
-
CSI 6.22rCSI 4.37%PRS 70.9
-
CSI 6.2rCSI 12.86%PRS 47.96
-
CSI 5.95rCSI 4.7%PRS 37.75
-
CSI 5.88rCSI 13.45%PRS 49.8
-
CSI 5.84rCSI 10.94%PRS 39.59
-
CSI 5.62rCSI 21.97%PRS 27.11
-
CSI 5.55rCSI 13.55%PRS 45.32
-
CSI 5.54rCSI 34.61%PRS 42.59
-
CSI 5.51rCSI 13.13%PRS 51.87
-
CSI 5.46rCSI 26.15%PRS 49.31
-
CSI 5.42rCSI 15.41%PRS 49.33
-
CSI 5.39rCSI 16%PRS 60.99
-
CSI 5.22rCSI 6.97%PRS 51.66
-
CSI 5.08rCSI 19.03%PRS 42.93
-
CSI 5.07rCSI 11.16%PRS 54.52
-
CSI 5.02rCSI 11.58%PRS 41
-
CSI 4.85rCSI 12.53%PRS 46.08
-
CSI 4.77rCSI 7.82%PRS 40.41
-
CSI 4.67rCSI 31.79%PRS 47.2
-
CSI 4.63rCSI 26.15%PRS 36.28
-
CSI 4.61rCSI 4.83%PRS 47.33
-
CSI 4.61rCSI 12.42%PRS 58.86
-
CSI 4.55rCSI 4.98%PRS 54.14
-
CSI 4.52rCSI 7.02%PRS 59.3
-
CSI 4.33rCSI 6.83%PRS 51.64
-
CSI 4.29rCSI 13.73%PRS 47.08
-
CSI 4.21rCSI 3.7%PRS 55.78
-
CSI 4.16rCSI 16.1%PRS 67.16
-
CSI 3.93rCSI 10.5%PRS 42.46
-
CSI 3.88rCSI 15.81%PRS 61.59
-
CSI 3.84rCSI 4.78%PRS 52.84
-
CSI 3.83rCSI 15.45%PRS 48.77
-
CSI 3.82rCSI 3.89%PRS 64.07
-
CSI 3.8rCSI 8.52%PRS 34.52
-
CSI 3.78rCSI 19.9%PRS 46.34
-
CSI 3.78rCSI 9.58%PRS 40.36
-
CSI 3.76rCSI 11.01%PRS 77.07
-
CSI 3.75rCSI 6.71%PRS 48.95
-
CSI 3.74rCSI 5.49%PRS 45.13
-
CSI 3.66rCSI 6.46%PRS 58.74
-
CSI 3.58rCSI 5.69%PRS 43.05
-
CSI 3.37rCSI 47.8%PRS 42.14
-
CSI 3.26rCSI 10.48%PRS 49.25
-
CSI 3.23rCSI 4.61%PRS 52.91
-
CSI 3.11rCSI 8.12%PRS 49.47
-
CSI 3.1rCSI 17.88%PRS 51.09
-
CSI 3.1rCSI 8.18%PRS 58.63
-
CSI 3.09rCSI 48.73%PRS 54.95
-
CSI 3.08rCSI 4.42%PRS 41
-
CSI 3.05rCSI 20.22%PRS 48.36
-
CSI 2.99rCSI 6.55%PRS 59.8
-
CSI 2.97rCSI 14.23%PRS 50.45
-
CSI 2.9rCSI 7.99%PRS 46.54
-
CSI 2.9rCSI 2.7%PRS 50.09
-
CSI 2.88rCSI 7.41%PRS 51.81
-
CSI 2.86rCSI 9.41%PRS 38.56
-
CSI 2.73rCSI 4.35%PRS 54.41
-
CSI 0.5rCSI 5.5%PRS 50.3%
-
CSI 0.5rCSI 1.5%PRS 48.9%
-
CSI 0.5rCSI 1.0%PRS 60.8%
-
CSI 0.6rCSI 6.5%PRS 73.4%
-
CSI 0.6rCSI 3.3%PRS 57.2%
-
CSI 0.7rCSI 3.0%PRS 35.6%
-
CSI 0.7rCSI 7.8%PRS 42.3%
-
CSI 0.8rCSI 5.6%PRS 45.0%
-
CSI 0.8rCSI 6.0%PRS 44.6%
-
CSI 1.0rCSI 0.8%PRS 49.7%
-
CSI 1.1rCSI 1.1%PRS 53.7%
-
CSI 1.1rCSI 1.3%PRS 46.2%
-
CSI 1.1rCSI 1.3%PRS 58.6%
-
CSI 1.1rCSI 1.7%PRS 46.9%
-
CSI 1.1rCSI 5.0%PRS 42.9%
-
CSI 1.1rCSI 5.6%PRS 62.1%
-
CSI 1.2rCSI 3.3%PRS 64.2%
-
CSI 1.2rCSI 2.7%PRS 48.0%
-
CSI 1.3rCSI 1.5%PRS 40.4%
-
CSI 1.3rCSI 3.3%PRS 58.7%
-
CSI 1.3rCSI 5.2%PRS 51.1%
-
CSI 1.3rCSI 6.2%PRS 46.5%
-
CSI 1.5rCSI 6.6%PRS 49.4%
-
CSI 1.5rCSI 13.9%PRS 65.2%
-
CSI 1.5rCSI 2.4%PRS 55.1%
-
CSI 1.6rCSI 13.4%PRS 37.6%
-
CSI 1.7rCSI 7.3%PRS 71.2%
-
CSI 1.7rCSI 3.7%PRS 64.8%
-
CSI 1.8rCSI 14.3%PRS 44.2%
-
CSI 1.8rCSI 11.6%PRS 54.8%
-
CSI 1.9rCSI 3.9%PRS 43.1%
-
CSI 2.1rCSI 16.2%PRS 47.1%
-
CSI 2.1rCSI 3.1%PRS 55.8%
-
CSI 2.1rCSI 2.5%PRS 48.3%
-
CSI 2.1rCSI 18.7%PRS 38.0%
-
CSI 2.2rCSI 7.3%PRS 37.4%
-
CSI 2.2rCSI 4.6%PRS 70.4%
-
CSI 2.2rCSI 13.5%PRS 69.3%
-
CSI 2.2rCSI 1.8%PRS 60.4%
-
CSI 2.3rCSI 3.1%PRS 45.6%
-
CSI 2.3rCSI 3.5%PRS 51.1%
-
CSI 2.3rCSI 5.5%PRS 38.9%
-
CSI 2.3rCSI 1.9%PRS 50.9%
-
CSI 2.3rCSI 2.9%PRS 61.6%
-
CSI 2.3rCSI 3.0%PRS 56.2%
-
CSI 2.3rCSI 6.1%PRS 49.1%
-
CSI 2.4rCSI 4.7%PRS 48.9%
-
CSI 2.4rCSI 3.5%PRS 66.9%
-
CSI 2.4rCSI 12.0%PRS 48.9%
-
CSI 2.5rCSI 2.2%PRS 65.2%
-
CSI 2.5rCSI 2.0%PRS 51.1%
-
CSI 2.5rCSI 15.0%PRS 46.7%
-
CSI 2.6rCSI 9.7%PRS 42.6%
-
CSI 2.6rCSI 6.0%PRS 66.5%
-
CSI 2.6rCSI 52.9%PRS 43.4%
-
CSI 2.6rCSI 2.1%PRS 51.3%
-
CSI 2.6rCSI 2.3%PRS 58.2%
-
CSI 2.7rCSI 3.9%PRS 52.6%
-
CSI 2.7rCSI 8.6%PRS 51.8%
-
CSI 2.7rCSI 64.4%PRS 34.1%
-
CSI 2.7rCSI 64.8%PRS 33.2%
-
CSI 2.7rCSI 2.1%PRS 68.4%
-
CSI 2.7rCSI 4.4%PRS 54.4%
-
CSI 2.9rCSI 9.4%PRS 38.6%
-
CSI 2.9rCSI 7.4%PRS 51.8%
-
CSI 2.9rCSI 2.7%PRS 50.1%
-
CSI 2.9rCSI 8.0%PRS 46.5%
-
CSI 3.0rCSI 14.2%PRS 50.5%
-
CSI 3.0rCSI 6.6%PRS 59.8%
-
CSI 3.1rCSI 20.2%PRS 48.4%
-
CSI 3.1rCSI 4.4%PRS 41.0%
-
CSI 3.1rCSI 48.7%PRS 55.0%
-
CSI 3.1rCSI 8.2%PRS 58.6%
-
CSI 3.1rCSI 17.9%PRS 51.1%
-
CSI 3.1rCSI 8.1%PRS 49.5%
-
CSI 3.2rCSI 4.6%PRS 52.9%
-
CSI 3.3rCSI 10.5%PRS 49.3%
-
CSI 3.4rCSI 47.8%PRS 42.1%
-
CSI 3.6rCSI 5.7%PRS 43.1%
-
CSI 3.7rCSI 6.5%PRS 58.7%
-
CSI 3.7rCSI 5.5%PRS 45.1%
-
CSI 3.8rCSI 6.7%PRS 49.0%
-
CSI 3.8rCSI 11.0%PRS 77.1%
-
CSI 3.8rCSI 9.6%PRS 40.4%
-
CSI 3.8rCSI 19.9%PRS 46.3%
-
CSI 3.8rCSI 8.5%PRS 34.5%
-
CSI 3.8rCSI 3.9%PRS 64.1%
-
CSI 3.8rCSI 15.5%PRS 48.8%
-
CSI 3.8rCSI 4.8%PRS 52.8%
-
CSI 3.9rCSI 15.8%PRS 61.6%
-
CSI 3.9rCSI 10.5%PRS 42.5%
-
CSI 4.2rCSI 16.1%PRS 67.2%
-
CSI 4.2rCSI 3.7%PRS 55.8%
-
CSI 4.3rCSI 13.7%PRS 47.1%
-
CSI 4.3rCSI 6.8%PRS 51.6%
-
CSI 4.5rCSI 7.0%PRS 59.3%
-
CSI 4.6rCSI 5.0%PRS 54.1%
-
CSI 4.6rCSI 12.4%PRS 58.9%
-
CSI 4.6rCSI 4.8%PRS 47.3%
-
CSI 4.6rCSI 26.2%PRS 36.3%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3822939450
Symbol: CDK8_HUMAN
Name: Cyclin-dependent kinase 8
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 7568034
Title: Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C.
PubMed ID: 7568034
PubMed ID: 15057823
Title: The DNA sequence and analysis of human chromosome 13.
PubMed ID: 15057823
DOI: 10.1038/nature02379
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 9734358
Title: NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription.
PubMed ID: 9734358
PubMed ID: 10024883
Title: A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation.
PubMed ID: 10024883
PubMed ID: 10993082
Title: TFIIH is negatively regulated by cdk8-containing mediator complexes.
PubMed ID: 10993082
DOI: 10.1038/35024111
PubMed ID: 15546612
Title: Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover.
PubMed ID: 15546612
PubMed ID: 15175163
Title: A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology.
PubMed ID: 15175163
PubMed ID: 15989967
Title: MED1/TRAP220 exists predominantly in a TRAP/Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.
PubMed ID: 15989967
PubMed ID: 17000779
Title: Mediator modulates Gli3-dependent Sonic hedgehog signaling.
PubMed ID: 17000779
DOI: 10.1128/mcb.00443-06
PubMed ID: 19369195
Title: Large-scale proteomics analysis of the human kinome.
PubMed ID: 19369195
PubMed ID: 30905399
Title: De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental Disorder.
PubMed ID: 30905399
PubMed ID: 21806996
Title: The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder.
PubMed ID: 21806996
PubMed ID: 17344846
Title: Patterns of somatic mutation in human cancer genomes.
PubMed ID: 17344846
DOI: 10.1038/nature05610
Sequence Information:
- Length: 464
- Mass: 53284
- Checksum: 00CBAB6CE354605F
- Sequence:
MDYDFKVKLS SERERVEDLF EYEGCKVGRG TYGHVYKAKR KDGKDDKDYA LKQIEGTGIS MSACREIALL RELKHPNVIS LQKVFLSHAD RKVWLLFDYA EHDLWHIIKF HRASKANKKP VQLPRGMVKS LLYQILDGIH YLHANWVLHR DLKPANILVM GEGPERGRVK IADMGFARLF NSPLKPLADL DPVVVTFWYR APELLLGARH YTKAIDIWAI GCIFAELLTS EPIFHCRQED IKTSNPYHHD QLDRIFNVMG FPADKDWEDI KKMPEHSTLM KDFRRNTYTN CSLIKYMEKH KVKPDSKAFH LLQKLLTMDP IKRITSEQAM QDPYFLEDPL PTSDVFAGCQ IPYPKREFLT EEEPDDKGDK KNQQQQQGNN HTNGTGHPGN QDSSHTQGPP LKKVRVVPPT TTSGGLIMTS DYQRSNPHAA YPNPGPSTSQ PQSSMGYSAT SQQPPQYSHQ THRY